BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24974475)

  • 1. [Modification by wheat germ agglutinin delays the ocular elimination of liposome].
    Zhang WJ; Yang DX; Feng LL; Wang F; Wei G; Lu WY
    Yao Xue Xue Bao; 2014 Apr; 49(4):543-9. PubMed ID: 24974475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration.
    Gao X; Tao W; Lu W; Zhang Q; Zhang Y; Jiang X; Fu S
    Biomaterials; 2006 Jun; 27(18):3482-90. PubMed ID: 16510178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface modification of liposomes using polymer-wheat germ agglutinin conjugates to improve the absorption of peptide drugs by pulmonary administration.
    Murata M; Yonamine T; Tanaka S; Tahara K; Tozuka Y; Takeuchi H
    J Pharm Sci; 2013 Apr; 102(4):1281-9. PubMed ID: 23389937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of wheat germ agglutinin density on cellular uptake and toxicity of wheat germ agglutinin conjugated PEG-PLA nanoparticles in Calu-3 cells.
    Shen Y; Chen J; Liu Q; Feng C; Gao X; Wang L; Zhang Q; Jiang X
    Int J Pharm; 2011 Jul; 413(1-2):184-93. PubMed ID: 21550388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery.
    Makhlof A; Fujimoto S; Tozuka Y; Takeuchi H
    Eur J Pharm Biopharm; 2011 Feb; 77(2):216-24. PubMed ID: 21147220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.
    Zhang N; Ping Q; Huang G; Xu W; Cheng Y; Han X
    Int J Pharm; 2006 Dec; 327(1-2):153-9. PubMed ID: 16935443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo toxicity and immunogenicity of wheat germ agglutinin conjugated poly(ethylene glycol)-poly(lactic acid) nanoparticles for intranasal delivery to the brain.
    Liu Q; Shao X; Chen J; Shen Y; Feng C; Gao X; Zhao Y; Li J; Zhang Q; Jiang X
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):79-84. PubMed ID: 21163285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(lactic acid) nanoparticles coated with combined WGA and water-soluble chitosan for mucosal delivery of β-galactosidase.
    Sheng Y; He H; Zou H
    Drug Deliv; 2014 Aug; 21(5):370-8. PubMed ID: 24797098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal transfer of wheat germ agglutinin modified lipid-polymer hybrid nanoparticles for oral delivery of oridonin.
    Liu Y; Liu J; Liang J; Zhang M; Li Z; Wang Z; Dang B; Feng N
    Nanomedicine; 2017 Oct; 13(7):2219-2229. PubMed ID: 28539275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nose-to-brain transport pathways of wheat germ agglutinin conjugated PEG-PLA nanoparticles.
    Liu Q; Shen Y; Chen J; Gao X; Feng C; Wang L; Zhang Q; Jiang X
    Pharm Res; 2012 Feb; 29(2):546-58. PubMed ID: 22167350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wheat germ agglutinin-grafted lipid nanoparticles: preparation and in vitro evaluation of the association with Caco-2 monolayers.
    Liu Y; Wang P; Sun C; Feng N; Zhou W; Yang Y; Tan R; Chen Z; Wu S; Zhao J
    Int J Pharm; 2010 Sep; 397(1-2):155-63. PubMed ID: 20599600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration.
    Gao X; Wu B; Zhang Q; Chen J; Zhu J; Zhang W; Rong Z; Chen H; Jiang X
    J Control Release; 2007 Aug; 121(3):156-67. PubMed ID: 17628165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of transcellular transport of wheat germ agglutinin-functionalized polymeric nanoparticles in Caco-2 cells.
    Song Q; Yao L; Huang M; Hu Q; Lu Q; Wu B; Qi H; Rong Z; Jiang X; Gao X; Chen J; Chen H
    Biomaterials; 2012 Oct; 33(28):6769-82. PubMed ID: 22705199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport characteristics of wheat germ agglutinin-modified insulin-liposomes and solid lipid nanoparticles in a perfused rat intestinal model.
    Zhang N; Ping Q; Huang G; Han X; Cheng Y; Xu W
    J Nanosci Nanotechnol; 2006; 6(9-10):2959-66. PubMed ID: 17048504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioadhesion and enhanced bioavailability by wheat germ agglutinin-grafted lipid nanoparticles for oral delivery of poorly water-soluble drug bufalin.
    Liu Y; Wang P; Sun C; Zhao J; Du Y; Shi F; Feng N
    Int J Pharm; 2011 Oct; 419(1-2):260-5. PubMed ID: 21816211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wheat germ agglutinin-conjugated liposomes incorporated with cardiolipin to improve neuronal survival in Alzheimer's disease treatment.
    Kuo YC; Lin CY; Li JS; Lou YI
    Int J Nanomedicine; 2017; 12():1757-1774. PubMed ID: 28280340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted systemic mesenchymal stem cell delivery using hyaluronate - wheat germ agglutinin conjugate.
    Kim YS; Kong WH; Kim H; Hahn SK
    Biomaterials; 2016 Nov; 106():217-27. PubMed ID: 27569867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescuing apoptotic neurons in Alzheimer's disease using wheat germ agglutinin-conjugated and cardiolipin-conjugated liposomes with encapsulated nerve growth factor and curcumin.
    Kuo YC; Lin CC
    Int J Nanomedicine; 2015; 10():2653-72. PubMed ID: 25878499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization.
    Glavas Dodov M; Calis S; Crcarevska MS; Geskovski N; Petrovska V; Goracinova K
    Int J Pharm; 2009 Nov; 381(2):166-75. PubMed ID: 19580856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.